Algenis
21 September 2018
Algenis specializes in the production, formulation, and clinical development of bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases.
You may be interested in...
-
LAVCA Week Update; SP Ventures exits InCeres; 1200VC commits to Lowercarbon
-
LAVCA Tech Brasil Recap; Linzor Capital Partners Invests in Peru’s Win
-
Proparco Invests in Linzor Fund IV
Proparco announced a USD15m commitment to Linzor Capital Partners’ fourth Private...
-
Credicorp Capital Invests in Colombia’s ExcelCredit
Credicorp Capital invested in ExcelCredit, a Colombia-based consumer lender....